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ABSTRACT: This study was aimed at determining the prevalence of Hepatitis B surface antigen (HBsAg) among 
prospective blood donors and pregnant women in Kebbi State, Nigeria. Three hundred and sixty one (361) apparently 
healthy prospective blood donors were recruited and screened for HBsAg using HBsAg rapid test kit. Those that 
tested positive for HBsAg (16.6%) were further assessed for liver function. The prevalence by gender was 23.4% and 
13.1% for male and female subjects respectively. Prevalence by the three senatorial zones of the state is in the order 
Kebbi South (21.8%) > Kebbi North (15.1%) > Kebbi Central (13.6%). Subjects within the age group 26-30 years had 
the highest HBsAg prevalence of 20.9% compared to the other age groups. Single males have higher prevalence 
(26.1%) of HBV infection than their married counterparts (16.7%). Local government workers had highest prevalence 
(29.2%) followed by self-employed (27.6%) and then state government employees (14.3%). In females, occupational 
exposure (healthcare worker) and polygamy are risk factors with highest prevalence of 40.0% and 23.2% 
respectively. The levels of serum liver enzymes and bilirubin were significantly higher (p < 0.05) in HBsAg positive 
subjects compared to the HBsAg negative subjects. The reverse was, however, the case for albumin. Our result 
suggests that Kebbi State is one of the HBsAg hyper-endemic areas in Nigeria.
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INTRODUCTION
Hepatitis B, also known as serum hepatitis is a disease 
of the liver caused by a double stranded DNA virus of 
the family Hepadnaviridae, which is reported to be the 
main aetiological factor in over 75% of chronic liver 
diseases worldwide (Ryan and Ray, 2004; Pungpapong 
et al., 2007; Oladele et al., 2013). Hepatitis B virus 
(HBV) is resistant to inactivation by heat and is highly 
infectious; it is 50-100 times more infectious than HIV 
and 10 times more infectious than hepatitis C. The virus 
is detected in virtually all body fluids (i.e. blood, saliva, 
semen, vaginal secretion, menstrual blood and to lesser 
extent in perspiration, breast milk, tears and urine) of 
infected individuals (Lavanchy, 2004; Elgouhari et al., 
2008).
HBV infection is among the leading public health 
burdens especially in developing countries (Samuel et 
al., 2004; Elgouhari et al., 2008). In high prevalence 
areas, the most common routes of HBV transmission are 
perinatal and horizontal transmissions (Gitlin, 1997; 
Hollinger and Liang, 2001). Also, heterosexual practices,
unprotected sex, injections, blood transfusion as well as 
sharing of sharp objects are among possible routes of 
transmission (Harry et al., 1994; Seeger and Mason, 
2000; Oladele et al., 2013).
An estimated 5% of the global population is infected with 
HBV, with more than 350 million people as chronic 
carriers and over 1 million deaths annually (WHO, 1998; 
Drosten et al., 2004; Sharma et al., 2005; Liu and Hou, 
2006; Ziraba et al., 2010; Eke et al., 2011). The 
prevalence of HBV varies significantly over the globe; 
low prevalence of 2% is reported in developed countries, 
while developing countries have prevalence of > 8.0% 
(Lule, 1997). Sub-Saharan Africa is HBV hyper-endemic, 
with 8-20% prevalence. Approximately 50 million people 
are chronic carriers (Drosten et al., 2004; Heathcote, 
2008; Majori et al., 2008; Ziraba et al., 2010).
HBV infection is a serious health challenge in Nigeria. 
Seventy five (75) percent of the total population is 
exposed to the infection at one time of their life or the 
other, with an estimated 12% prevalence of chronic 
carriers (Alao et al., 2009; Oladele et al., 2013). Due to 
the infectious and asymptomatic nature of HBV infection, 
poor health care facilities and inadequate monitoring of 
HBV infection, controlling the spread of HBV infection 
remain a major challenge (Okoye and Samba, 2006).
The prevalence of HBV infection is disproportionate 
within the Nigerian population (Alao et al., 2009). Bello et 
al., (2013) reported 14.0% prevalence among patients 
visiting Sokoto Specialist Hospital, Sokoto. More so, a 
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prevalence of 7.9% and 7.6% were reported for pregnant 
and nonpregnant women respectively attending Aminu 
Kano Teaching Hospital, Kano (Yakasai et al., 2012). 
Study of ante-natal patients attending various clinics in 
Gwagwalada metropolis of Abuja revealed 9.5% 
prevalence (Agarry and Lekwot, 2010). Forbi et al. 
(2008) reported a prevalence of 17.1% among female 
sex workers in Nasarawa State. A prevalence of 9.0% in 
Mubi and 8.2% among pregnant women in Yola of 
Adamawa State was reported by Okoye and Samba, 
(2006) and Olokoba et al. (2011) respectively. In Jos, 
Plateau State, a prevalence of 20.8% was reported by 
Adekeye et al., (2013).  Angyo et al., (1995) reported 
19.5% prevalence among children attending Jos 
University Teaching Hospital, Plateau State.
This study was aimed at determining the prevalence of 
HBV among prospective blood donors and pregnant 
women in Kebbi State and assessment of liver function 
of the HBV infected subjects.
MATERIALS AND METHODS
Study Area and Population
Three hundred and sixty one (361) apparently healthy 
blood donors and pregnant women within the age of 18-
35 years, attending Argungu General Hospital, Sir 
Yahaya Specialist Hospital Birnin Kebbi and Martha 
Bamaiyi General Hospital Zuru all in Kebbi State, 
Nigeria, who willingly consented to participate in the 
study, were screened for HBV infection between the 
months of January to December, 2012. Subjects with 
established cases of liver disease and/or HIV infection 
where excluded from the study. Questionnaire was 
administered to obtain additional information/ history of 
each participant.
Ethical Approval
This research was approved by the ethical committee of 
Kebbi State Ministry of Health, Birnin Kebbi, Kebbi State, 
Nigeria.
Sample Collection and Preparation
Five milliliters of venous blood were collected from each 
participant using sterile syringe and transferred into plain 
specimen bottles. The blood was allowed to clot for 30 
minutes, and then centrifuged at 2500 rpm for five 
minutes. The serum obtained was used for the analyses.
HBV Analysis/ Test
Serum samples were tested for the presence of HBV 
infection using HBsAg rapid test kit (ACON, USA) which 
is based on the principle of antigen-antibody reaction. 
The test and interpretation of results were carried out 
based on the manufacturer’s specifications and 
guidelines.
Liver Function Test and Prothrombin Time 
Estimation
HBsAg positive subjects were further screened for liver 
function parameters. Standard methods were used to 
determine Total Protein (Weichselbaum, 1946), Albumin 
(Doumas et al., 1971), Total Bilirubin (Doumas et al., 
1973), Direct Bilirubin (Doumas et al., 1973), Aspartate 
aminotransferase (AST) (Reitman and Frankel, 1957), 
Alanine aminotransferase (ALT) (Reitman and Frankel, 
1957), Alkaline Phosphatase (ALP) (Tietz et al., 1983) 
and Prothrombin Time (Quick, 1935). HBsAg negative 
subjects served as controls.
Data Analysis
Data obtained for liver function parameters were 
expressed as Mean ± Standard deviation. All the 
parameters were analysed statistically at P<0.05 by one-
way analysis of variance (ANOVA) using GraphPad 
InStat Software (Version 3.05, San Diego, USA).
RESULT AND DISCUSSION
The prevalence of HBV infection among prospective 
blood donors and pregnant women in Kebbi State is 
presented in Table 1. 
Table 1: Prevalence of HBsAg in Kebbi State, Nigeria




















The result reveal that Kebbi State has a high prevalence 
of HBV (16.6%), thus, is hyper-endemic. Males exhibited 
a higher prevalence of 23.4% as compared to females 
with 13.1%. This finding agrees with earlier reports 
(Oladele et al., 2013) classifying Nigeria as a HBV 
endemic region.
Based on senatorial district, Kebbi South has the highest 
prevalence rate (21.8%), followed by Kebbi North 
(15.1%), while Kebbi Central has the least prevalence 
(13.6%) (Table 2). Higher prevalence in Kebbi South and 
Kebbi North as compared to Kebbi Central may be 
attributed to poor awareness and counseling as well as 
difficulty in accessing healthcare facilities. Occupational 
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and mechanical transfers are also possible means of 
transmission in these areas, which is due to low socio-
economic status and remoteness of the zones. 
The prevalence of HBV among age groups in Kebbi 
State is shown in Table 3. A high prevalence of 20.9% 
was observed among 26-30 years age group. This is 
presumed to be due to the more sexually active life of 
youth at the stated age (Khan et al., 2011). Also, optimal 
social interactions and occupational interest (especially 
in self-employed) are observed within the stated age, 
thus, may be additional causes of exposure (Khan et al., 
2011).
The prevalence of HBV by risk factors for males and 
females in Kebbi State are presented in Tables 4 and 5 
respectively. Though, all the male subjects denied 
casual sex life style, a higher prevalence of HBV (26.1%) 
was observed in single subjects when compared to 
married subjects (16.7%).
Also, male subjects having a history of sharing sharp 
objects had an extremely high prevalence of HBV 
infection (80.6%). This concurs with reports of Khan et 
al. (2011) which suggests that sharing of sharp objects 
or needles is a possible route of HBV transmission due 
to its high infectious potential (Samuel et al., 2004).
For female participants, polygamy (2nd marriage) and 
occupational exposure (healthcare workers) are risk 
factors with highest prevalence (23.2% and 40.0% 
respectively). Our findings agree with the report of 
Olubiyide et al. (1997), which suggest that occupational 
exposure can be a major route of HBV transmission.
Liver Function Parameters and Prothrombin Time of 
HBsAg positive and HBsAg negative subjects are 
presented in Table 6. The level of aspartate 
aminotransferase (AST) and alanine aminotransferase 
(ALT) of HBsAg positive subjects were significantly 
higher (p< 0.05) than that of HBsAg negative subjects, 
indicating liver injury. Also, elevated ALT (above ratio 1 
of AST) observed in HBsAg positive subjects is an 
indication of viral hepatitis. A significant decline (p < 
0.05) in albumin level was observed in HBsAg positive 
subjects, indicating liver injury and corresponding 
decrease in protein synthesis by the liver (Whitby et al., 
1988). The HBsAg positive subjects have significantly 
higher (p< 0.05) levels of total and direct bilirubin when 
compared to HBsAg negative subjects, these concur to 
the report of Rozen et al. (1970). Also observed is 
significant elevation (p< 0.05) of prothrombin time by 
more than 1.0 second above the upper reference limit, 
which is an indication of defect by hepatocytes to 
produce functional coagulation factors (Bonacini et al., 
1997). Thus, indicating liver injury.
Table 2: Prevalence of HBsAg by Senatorial Zones of Kebbi State, Nigeria
Senatorial Zone No. of Screened subject No. of   HBsAg +ve Subjects Prevalence (%)
Kebbi Central 125 17 13.6
Kebbi North 126 19 15.1
Kebbi South 110 24 21.8
Table 3: Prevalence of HBsAg by Age Group in Kebbi State, Nigeria
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Table 4: Prevalence of HBV Infection by Risk Factors among Male* Participants in Kebbi State




















































































*Total number of male participants= 124
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Table 5: Prevalence of HBV Infection by Risk Factors among Female* Participants in Kebbi State


























































































*Total number of female participants= 237
Table 6: Liver Function Parameters and Prothrombin Time of HBsAg Positive and HBsAg Negative Subjects
Parameters        HBsAg Positive Subjects HBsAg Negative Subjects































Values are expressed as Mean ± Standard Deviation, Mean values with different superscripts in a row indicate significant 
difference (p < 0.05), AST = Aspartate aminotransferase, ALT = Alanine aminotransferase, * = 29 Subjects, ** = 31 Subjects, 
*** = 95 Subjects, **** = 206 Subjects.
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CONCLUSION
The result of this study reveals that Kebbi State is HBV 
hyper-endemic, with males having higher prevalence 
than females. More so, subjects with history of sharing 
sharp objects and those with occupational exposure 
(healthcare workers) had high HBV prevalence.  
Therefore, there is need for continuous routine screening 
and rigorous awareness as well as vaccination of the 
populace so as to tackle the menace of HBV infection in 
Kebbi State. 
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